Nhà máy Stada
Stada
stada
stada
Antidiabetic Agents

Staclazide 30 MR

Packaging: Blister of 10 tablets. Box of 3 blisters.

Composition: 30 mg Gliclazide

Shelf - Life:

 36 months from the date of manufacturing.

  • Indications
  • Contraindications
  • Adverse reactions
  • Dosage

Non insulin dependent diabetes mellitus.

  • Gliclazide should not be used in:
  • Juvenile onset diabetes.
  • Diabetes complicated by ketosis and acidosis.
  • Pregnancy.
  • Diabetics undergoing surgery, after severe trauma or during infections.
  • Patients known to have hypersensitivity to other sulfonylureas and related drugs.
  • Diabetic pre-coma and coma.
  • Severe renal or hepatic insufficiency.

Pregnancy and Lactation:

  • Pregnancy: See “Contraindications”.
    Lactation: Some sulfonylureas are distributed into breast milk and the class of drugs should be avoided during breast feeding.

  • Gastrointestinal disturbances such as nausea, vomiting, heartburn, anorexia, diarrhoea, and a metallic taste may occur with sulfonylureas and are usually mild and dose-dependent; increased appetite and weight gain may occur. Skin rashes and pruritus may occur and photosensitivity has been reported. Rashes are usually hypersensitivity reactions and may progress to more serious disorders. Facial flushing may develop in patients receiving sulfonylureas.
  • Mild hypoglycaemia may occur, severe hypoglycaemia is usually an indication of overdosage and is relatively uncommon.
  • Other severe effects may be manifestations of a hypersensitivity reaction. They include altered liver enzyme values, hepatitis and cholestatic jaundice, leucopenia, thrombocytopenia, aplastic anaemia, agranulocytosis, haemolytic anaemia, erythema multiforme or the Stevens-Johnson syndrome, exfoliative dermatitis, and erythema nodosum.

  • Staclazide 30 MR is a sulfonylurea antidiabetic. It is given by mouth in the treatment of type 2 diabetes mellitus and has a duration of action of 12 to 24 hours. Because its effects are less prolonged than those of chlorpropamide or glibenclamide it may be more suitable for elderly patients, who are prone to hypoglycaemia with longer-acting sulfonylureas.
  • The usual initial dose is 30 mg once daily, increased if necessary up to a maximum of 120 mg daily

Contact us

FACTORY 1: K63/1 Nguyen Thi Soc St., Xuan Thoi Dong, Hoc Mon, HCMC
Tel: +84 28 3718 2141 - Fax: +84 28 3718 2140

FACTORY 2: 40 Tu Do Avenue, VietNam-Singapore Industrial Park, Binh Duong
Tel: +84 274 376 7470 - Fax: +84 274 376 7469
Email : stada@stada.com.vn
Website: www.stada.com.vn



Visitors Counter

Online
36
Total